International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 786-794 doi: 10.5281/zenodo.16901915
Original Article
A Study of Psychiatric Co-Morbidities in Post Covid-19 Survivors in a Tertiary Care Hospital
 ,
 ,
 ,
 ,
Published
Aug. 19, 2025
Abstract

Aim: The aim of the present study was to assess the psychiatric comorbidities, such as Depression, Anxiety, and obsessive-compulsive disorder, among COVID-19 survivors.

Methods: The study was conducted in the inpatient (IPD) and outpatient (OPD) departments of Psychiatry and Obstetrics & Gynecology at the National Institute of Medical Sciences & Research, Jaipur, Rajasthan, India. The study was carried out over a period of 18 months and 143 patients were included in the study.

Results: The mean age of participants was 46.40 ± 11.74 years. The majority of participants were aged between 46 and 60 years. A larger proportion of the sample were males (71.3%, 102 participants) compared to females (28.7%, 41 participants). The mean height of participants was 170.14 ± 10.69 cm, and the mean weight was 69.83 ± 11.59 kg. The average Body Mass Index (BMI) was 24.40 ± 5.16. The majority of participants had a secondary or middle school education level. In terms of socioeconomic status, the medium category was the most prevalent. Geographically, more participants came from rural areas compared to urban areas. In terms of clinical findings related to COVID-19 history, the mean duration of hospital stay among the participants was 2.54 ± 3.77 days. Regarding a history of psychiatric illness in the family, 23.8% (34 participants) reported a family history of psychiatric disorders. The General Health Questionnaire (GHQ) results indicated that the mean GHQ score among participants was 5.40 ± 4.02.

Conclusion: The findings of this study underscore the significant mental health burden faced by individuals who have recovered from COVID-19, particularly in relation to psychiatric disorders such as Depression, Anxiety, and obsessive-compulsive disorder (OCD). These conditions are prevalent among post-COVID survivors and are associated with various demographic and clinical factors, including age, gender, and the severity of the initial COVID-19 infection

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
2856 Views
59 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved